Literature DB >> 15227841

[Treatment of craniopharyngiomas in children].

Keiichi Sakai1, Yuichiro Tanaka, Kazuhiro Hongo, Tsuyoshi Tada, Hiroaki Shigeta, Shigeaki Kobayashi.   

Abstract

PURPOSE: The purpose of this article is to assess, in a 25-year retrospective study, the clinical outcome in children with craniopharyngioma. PATIENT AND METHODS: From 1978 to 2002, 12 children younger than 15-year-old underwent treatment with surgery and/or radiotherapy for craniopharyngioma. The clinical course and outcome were reviewed.
RESULTS: The median age was 7.3 years (range, 3 to 12 years) at the time of initial surgical resection. With a mean follow-up period of 132 months (range, 29 to 255 months), 1 patient died of tumor progression due to malignant transformation at 205 months after the initial surgery and the overall outcome was good in 11 patients. Out of 12 patients 4 presented a recurrence of their tumor, 2 after an apparently gross total removal. Because of tumor recurrence, 2 received conventional radiation therapy and 3 received gamma knife radiosurgery. There was neither operative mortality nor major complication. All patients required hormonal replacement postoperatively.
CONCLUSIONS: The goal in the treatment of craniopharyngiomas is to achieve total removal without morbidity. Our results compared favorably with the previous reports in the literature. MRI follow-up should be performed even in patients whose primary tumor is resected "completely". Suitable combination of open surgery, conventional radiotherapy and gamma knife radiosurgery may result in optimal functional outcome. Recovery from postoperative pituitary dysfunction can be occasionally expected.

Entities:  

Mesh:

Year:  2004        PMID: 15227841

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


  4 in total

Review 1.  De novo malignant craniopharyngioma: case report and literature review.

Authors:  Libero Lauriola; Francesco Doglietto; Mariangela Novello; Francesco Signorelli; Nicola Montano; Roberto Pallini; Giulio Maira
Journal:  J Neurooncol       Date:  2010-09-03       Impact factor: 4.130

2.  The cell-cycle kinetics of craniopharyngioma and its clinical significance.

Authors:  Jianguo Xu; Chao You; Liangxue Zhou; Qiang Li; Peizhi Zhou; Ni Chen
Journal:  J Neurooncol       Date:  2009-11-24       Impact factor: 4.130

3.  Sequential pathological changes during malignant transformation of a craniopharyngioma: A case report and review of the literature.

Authors:  Tetsuya Negoto; Kiyohiko Sakata; Takachika Aoki; Kimihiko Orito; Shinji Nakashima; Masaru Hirohata; Yasuo Sugita; Motohiro Morioka
Journal:  Surg Neurol Int       Date:  2015-03-30

4.  Expression of human MCM6 and DNA Topo II alpha in craniopharyngiomas and its correlation with recurrence of the tumor.

Authors:  Jianguo Xu; Sizhong Zhang; Chao You; Siqing Huang; Bowen Cai; Xiaojie Wang
Journal:  J Neurooncol       Date:  2007-04-05       Impact factor: 4.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.